No description available.

In this thesis, we describe the development of a method to delete and to clone specific large regions from the 1700 kilobase pExo megaplasmid of Rhizobium meliloti. In principal, the region to be cloned is flanked by FRT sites, which direct site specific recombination by the Flp recombinase. Targeting constructs were designed to include part of the IS50 from Tn5, the FRT site, an origin of transfer (oriT), and a replication origin from RK2 or the F plasmid. These constructs were directed to known Tn5-derivative insertion sites in the pExo megaplasmid. A plasmid which expresses the Flp recombinase constitutively in R. meliloti was made, and the transfer of this plasmid to FRT-flanked megaplasmid regions was shown to result in the deletion of the intervening DNA. We demonstrated that the pExo megaplasmid DNA regions could be captured in Escherichia coli, however in this case, the megaplasmid excision event appears to be directed by the oriT sites rather than the FRT sites. We present strong evidence that a specific 50 kb region contains the oriV of the pExo megaplasmid; R. meliloti strains deleted for this region could not be isolated, and this region was found to replicate autonomously in Agrobacterium tumefaciens. Preliminary sequence analysis has revealed strong homology within this region to genes encoding the RepABC replication proteins of several Rhizobium and Agrobacterium plasmids. / Thesis / Master of Science (MS)

No description available.

No description available.

The technique of restriction fragment length polymorphism (RFLP) analysis, of chloroplastic and genomic DNA, was investigated as a means of identifying eucalypt species and cultivars which are morphologically indistinguishable from one another. In order to resolve chloroplast DNA (cpDNA) RFLPs, a method was developed to extract high yields of intact chloroplasts from Eucalyptus grandis S/N M6. Starch contamination was reduced by incubation of saplings in the dark for 48 h prior to extraction and watering with a solution containing 370 mM Na-phosphate and 296 mM KN03. Optimal chloroplast yields (25 ug chlorophyll/g fresh mass) were obtained by chopping leaf material, using a vertical homogenizer, in a buffer containing 350 mM sorbitol, 50 mM tris-HCL and 5 mM EDTA, 0.1 % (w/v) bovine serum albumin, 0.15 % (w/v) 2-mercaptoethanol, 2 mM L-ascorbic acid and 1 mM MgCI2 followed by washing of leaf pieces in a buffer containing only sorbitol, tris-HCL and EDTA. When these chloroplasts were used in an "in-organelle" DNA digestion procedure, polymorphisms were observed between the cpDNA profiles resolved for E. grandis S/N M6 and that of an outgroup species (spinach). However, the developed chloroplast extraction technique could not be used to obtain chloroplasts from various other eucalypt species, probably as a result of variability in the material at an ultrastructural or biochemical level. For the analysis of genomic DNA RFLPs, a DNA extraction procedure was optimized for use with various eucalypt species and cultivars. This included the development of a purifcation technique during which DNA was ammonium acetate-ethanol precipitated and subjected to mini-dialysis. Following Dra I restriction of DNA, the extract was electrophoresed and Southern blotted onto both nylon and nitrocellulose membranes. These were probed with a Hind-III restricted sample of the multilocus plasmid probe pV47-2. This probe was labelled using 32p as well as a non-radioactive labelling substance digoxygenin (DIG). Hybridization conditions, including the composition of the hybridization buffer, were optimized for use with these labels, and DNA RFLPs (fingerprints) were resolved for the eucalypt species E. grandis and E. macarthurii and cultivars of E. grandis (S/N M6, TAG 5 and TAG 14). An average of 8.5 bands were detected with 32p and 5.0 fragments with DIG. All the species and cultivars fingerprinted with the 32P-label could be distinguished from one another. However, as a result of the reduced sensitivity of the DIG system, two of the E. grandis cultivars, S/N M6 and TAG 5, could not be differentiated. It is concluded that the latter system would be most suitable for incorporation into a routine eucalypt screening programme, although it is suggested that the colourimetric detection assay, used in this study to resolve DNA bands, be replaced by a more sensitive one. / Thesis (M.Sc)-University of Natal, Durban, 1993.

Made available in DSpace on 2014-10-09T12:48:41Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T14:01:04Z (GMT). No. of bitstreams: 1 09151.pdf: 3898995 bytes, checksum: c6107a524057a95f300eee8a635c6f1e (MD5) / Dissertacao (Mestrado) / IPEN/D / Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP

Made available in DSpace on 2014-10-09T12:35:39Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T14:03:56Z (GMT). No. of bitstreams: 0 / Tese (Doutoramento) / IPEN/T / Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP

Made available in DSpace on 2014-10-09T12:48:41Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T14:01:04Z (GMT). No. of bitstreams: 1 09151.pdf: 3898995 bytes, checksum: c6107a524057a95f300eee8a635c6f1e (MD5) / Dissertacao (Mestrado) / IPEN/D / Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP

Made available in DSpace on 2014-10-09T12:35:39Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T14:03:56Z (GMT). No. of bitstreams: 0 / Níveis sustentáveis de hormônio de crescimento humano (hGH) circulante e aumento de peso altamente significativo, avaliados também em comparação a repetidas injeções de hormônio, foram observados em trabalhos anteriores, baseados na eletrotransferência de DNA plasmidial no músculo de camundongos anões imunodeficientes (lit/scid). No presente trabalho, um modelo animal homólogo de terapia gênica para GH foi estudado mediante clonagem da sequência genômica do DNA de GH de camundongo (mGH-gDNA), a qual substituiu o hGH-gDNA no vetor que havia sido utilizado em camundongos anões imunodeficientes. O novo vetor, agora nomeado UBI-mGH-gDNA, foi utilizado em camundongos anões imunocompetentes (lit/lit). Foi primeiramente realizado um teste in vitro, transfectando-se células humanas HEK 293 com este plasmídeo e obtendo-se uma expressão de 3,0 &mu;g mGH/106 células/dia, contra 3,7 &mu;g mGH/106 células/dia, para o UBI-hGH-gDNA. Estes dois plasmídeos foram então injetados (50 &mu;g/animal) no músculo quadríceps de camundongos, seguido de eletroporação, realizando um ensaio de 94 dias. Enquanto após 15 dias, as inclinações das curvas de variação de peso relacionadas ao mGH, hGH e salina foram 0,130, 0,112 e 0,027 g/camundongo/dia, respectivamente, após 94 dias, as inclinações correspondentes foram 0,041, 0,028 e 0,033 g/camundongo/dia. As análises estatísticas mostraram que após 15 dias, as inclinações das duas curvas com o GH foram significativamente maiores que a inclinação do controle (P<0,001), enquanto que após 94 dias, somente a inclinação da curva do mGH foi maior que a do controle (P<0,005). A porcentagem de aumento de peso nos animais tratados com o gene do mGH, após 94 dias, foi de 34,3%, enquanto que o comprimento nariz-cauda e o comprimento do fêmur, dois parâmetros que medem diretamente o crescimento longitudinal, foram de 9,5% e 26%, respectivamente, quando comparados aos valores iniciais. A interrupção do crescimento progressivo do grupo tratado com hGH não foi inesperada, considerando a óbvia reação imunogênica dos animais imunocompetentes contra o GH humano e não contra o de camundongo (título do anticorpo anti-hGH 1:100 a 1:3200). A inclinação altamente positiva do grupo controle, já observada em camundongos lit/lit mas não em lit/scid, é provavelmente devida ao ganho de peso natural desta linhagem, não suportada, contudo, por um proporcional crescimento longitudinal. Níveis circulatórios de mGH da ordem de 4 ng/mL foram detectados após 15 dias para o grupo tratado com o mGH, enquanto o grupo controle apresentou níveis em torno de 0,7 ng mGH/mL (P<0,001). Níveis circulatórios de mIGF-I foram também determinados nos dias 15, 45 e 94 nos animais tratados com mGH, sempre mostrando valores 1,5 - 3,0 vezes maiores que o grupo controle, e valores 1,2-1,6 vezes maiores que o grupo tratado com hGH. Este modelo de tratamento homólogo pode ser considerado uma primeira abordagem e um importante suporte para futuros ensaios pré-clínicos baseados na administração de DNA plasmidial para o tratamento da deficiência de GH humano. / Tese (Doutoramento) / IPEN/T / Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP

Submitted by Claudinei Pracidelli (cpracide@ipen.br) on 2014-11-10T11:09:13Z No. of bitstreams: 0 / Made available in DSpace on 2014-11-10T11:09:13Z (GMT). No. of bitstreams: 0 / Dissertação (Mestrado em Tecnologia Nuclear) / IPEN/D / Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP